Buscar
21/11/2021
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
Zeymert, U, Ludman, P, Danchin, N, Kala, P, Laroche, C, Sadeghi, M, Caporale, R, Shaheen, SM, Legutko, J, Iakobsishvili, Z, Alhabib, KF, Motovska, Z, Studencan, M, Mimoso, J, Becker, D, Alexopoulos, D, Kereseselidze, Z, Stojkovic, S, Zelveian, P, Goda, A, Mirrakhimov, E, Bajraktari, G, Al-Farhan, H, Serpytis, P, Raungaard, B, Marandi, T, Moore, AM, Quinn, M, Karjalainen, PP, Tatu-Chitolu, G, Gale, CP, Maggioni, AP, Weidinger, F, Sionis A., ESC. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. EUROPEAN HEART JOURNAL. 2021; 42(44)DOI:10.1093/eurheartj/ehab342. PMID:34389857. IF:35.855(Q1/1D).
12/11/2021
Systematic Characterization of High-Power Short-Duration Ablation: Insight From an Advanced Virtual Model.
Petras A, Moreno Weidmann Z, Leoni M, Gerardo-Giorda L, Guerra JM. Systematic Characterization of High-Power Short-Duration Ablation: Insight From an Advanced Virtual Model.. Frontiers In Medical Technology. 2021; 3DOI:10.3389/fmedt.2021.747609. PMID:35047958. IF:(Q/D).
11/11/2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Pfeffer, MA, Claggett, B, Lewis, EF, Granger, CB, Kober, L, Maggioni, AP, Mann, DL, McMurray, JJV, Rouleau, JL, Solomon, SD, Steg, PG, Berwanger, O, Cikes, M, De Pasquale, CG, East, C, Fernandez, A, Jering, K, Landmesser, U, Mehran, R, Merkely, B, Mody, FV, Petrie, MC, Petrov, I, Schou, M, Senni, M, Sim, D, van der Meer, P, Lefkowitz, M, Zhou, Y, Gong, J, Braunwald, E, Sionis A., PARADISE-MI Invest & Comm. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. NEW ENGLAND JOURNAL OF MEDICINE. 2021; 385(20)DOI:10.1056/NEJMoa2104508. PMID:34758252. IF:176.082(Q1/1D).
02/09/2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Gerstein, HC, Sattar, N, Rosenstock, J, Ramasundarahettige, C, Pratley, R, Lopes, RD, Lam, CSP, Khurmi, NS, Heenan, L, Del Prato, S, Dyal, L, Branch, K, Sionis A., AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE. 2021; 385(10)DOI:10.1056/NEJMoa2108269. PMID:34215025. IF:176.082(Q1/1D).
12/02/2024
Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure.
de la Espriella R, Núñez-Marín G, Cobo M, de Castro Campos D, Llácer P, Manzano L, Zegrí I, Rodriguez-Pérez Á, Santas E, Lorenzo M, Miñana G, Núñez E, Górriz JL, Bayés-Genís A, Fudim M, Mullens W, Núñez J. Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure.. JACC-Heart Failure. 2024; 12(2)DOI:10.1016/j.jchf.2023.07.015. PMID:37676214. IF:11.800(Q1/1D).
01/01/2024
HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk.
Aguado-Sierra J, Brigham R, Baron AK, Gomez PD, Houzeaux G, Guerra JM, Carreras F, Filgueiras-Rama D, Vazquez M, Iaizzo PA, Iles TL, Butakoff C. HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk.. Methods In Molecular Biology. 2024; 2716DOI:10.1007/978-1-0716-3449-3_14. PMID:37702946. IF:(Q/D).
01/01/2024
Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry.
Cobo Marcos M, de la Espriella R, Gayán Ordás J, Llàcer P, Pomares A, Fort A, Ponz de Antonio I, Méndez A, Blázquez-Bermejo Z, Caravaca Pérez P, Rubio Gracia J, Recio-Mayoral A, Zegrí I, García Pinilla JM, Montero Hernández E, Castro A, Soler MJ, Górriz JL, Bascompte Claret R, Fluvià-Brugués P, Manzano L, Núñez J. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry.. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(1)DOI:10.1016/j.rec.2023.05.003. PMID:37217135. IF:(Q/D).
01/01/2024
Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.
Cabezón-Villalba G, Barge-Caballero E, González-Vílchez F, Castel-Lavilla MÁ, Gómez-Bueno M, Almenar-Bonet L, González-Costello J, Lambert-Rodríguez JL, Martínez-Sellés M, de la Fuente-Galán L, Mirabet-Pérez S, García-Cosío Carmena MD, Hervás-Sotomayor D, Rangel-Sousa D, Blasco-Peiró T, Garrido-Bravo IP, Rábago Juan-Aracil G, Muñiz J, Crespo-Leiro MG. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(1)DOI:10.1016/j.rec.2023.05.002. PMID:37217134. IF:(Q/D).